Orbimed royalty opportunities
WebSep 29, 2024 · WHEREAS, Royalty Opportunities is the registered holder of a Convertible Promissory Note in the aggregate principal amount of $809,613.67 issued on April 14, 2016 and Convertible Promissory Notes in the aggregate principal amounts of $564,300 and $24,288.41 issued on January 17, 2024, in each case, by the Company (collectively, the “ … WebJan 18, 2024 · On January 17, 2024, and as contemplated by the Restructuring Agreement, ROS and OrbiMed converted the Notes issued to them in January 2024 in the aggregate principal amount of $1.627 million, plus accrued and unpaid interest, at the $0.7589 per share conversion rate originally provided thereunder, into approximately 2.3 million shares …
Orbimed royalty opportunities
Did you know?
WebJan 30, 2024 · WHEREAS, Royalty Opportunities is the registered holder of a Convertible Promissory Note in the aggregate principal amount of $809,613.67 issued on April 14, 2016 by the Company (the “ Royalty Opportunities Note ” and together with the ROS Note, collectively, the “ Notes ”); WebNov 14, 2024 · WHEREAS, the Borrowers, ROS and Royalty Opportunities are party to that certain Amended and Restated Credit Agreement, dated as of July 27, 2015, as amended by that certain First Amendment to Amended and Restated Credit Agreement, dated as of March 31, 2016, that certain Second Amendment to Amended and Restated Credit …
WebFeb 24, 2024 · $50 Million Drawn on Second Tranche from OrbiMed Royalty & Credit Opportunities III, LP (OrbiMed), Cash Received on November 4, 2024 Continue to Enroll OLYMPIA Phase 2 Clinical Trial, Study... WebWHEREAS, Royalty Opportunities is the registered holder of a Convertible Promissory Note in the aggregate principal amount of $809,613.67 issued on April 14, 2016 and Convertible Promissory Notes in the aggregate principal amounts of $564,300 and $24,288.41 issued on January 17, 2024, in each case, by the Company (collectively, the “ Royalty …
WebOct 18, 2024 · In August, the company secured $125 million in debt financing from OrbiMed Royalty & Credit Opportunities. The agreement provides for loans in three separate tranches: $45 million up front;... WebWe believe that if we treat our employees like royalty they will treat our customers like royalty. Our customer-oriented culture places the emphasis on Customer Service, …
WebOrbiMed Royalty & Credit Opportunities IV, LP: Street Address 1 Street Address 2; 601 LEXINGTON AVENUE: 54TH FLOOR: City State/Province/Country ZIP/PostalCode Phone …
WebSep 17, 2024 · THIS CERTIFIES THAT, for value received, ORBIMED ROYALTY OPPORTUNITIES II, LP or its successors or permitted assigns (such Person and such successors and assigns each being the “Warrant Holder” with respect to the Warrant held by it), at any time and from time to time on any Business Day on or prior to 5:00 p.m. high five to the facehigh five training arpaWebOrbiMed has raised a total of $8.6B across 14 funds, their latest being OrbiMed Asia Partners IV. This fund was announced on Mar 1, 2024 and raised a total of $800M. … how humans are impacting water resourcesWebEighteenth Amendment and Waiver to Amended and Restated Credit Agreement, dated as of September 29, 2024, by and among Bacterin International, Inc., Xtant Medical Holdings, Inc., X-Spine Systems, Inc., Xtant Medical, Inc., ROS Acquisition Offshore LP and OrbiMed Royalty Opportunities II, LP from Xtant Medical Holdings, Inc. filed with the Securities and … high five to goWebWHEREAS, Royalty Opportunities is the registered holder of a Convertible Promissory Note in the aggregate principal amount of $809,613.67 issued on April 14, ... ORBIMED … high fivetm细胞WebOrbiMed (also known as OrbiMed Advisors) is an American investment firm based in New York City, United States. It is focused on making public and private investments in the … how humans are evolving with technologyWebThis RESTRUCTURING AND EXCHANGE AGREEMENT, dated as of August 7, 2024 (this “ Agreement ”), by and among: (i) Xtant Medical Holdings, Inc. (the “ Company ”); and (ii) OrbiMed Royalty Opportunities II, LP, as a lender under the Existing Credit Agreement (in such capacity, “ OrbiMed ”) and ROS Acquisition Offshore LP, as a lender under the … high five too slow